Helicobacter pylori promotes hepatic fibrosis in the animal model

Laboratory Investigation

Volumn 89, Issue 11, 2009, Pages 1291-1303

  Goo, Moon Jung ^a   Ki, Mi Ran ^a   Lee, Hye Rim ^a   Yang, Hai Jie ^a   Yuan, Dong Wei ^a   Hong, Il Hwa ^a   Park, Jin Kyu ^a   Hong, Kyung Sook ^a   Han, Jung Youn ^a   Hwang, Ok Kyung ^a   Kim, Dong Hwan ^a   Do, Sun Hee ^b   Cohn, Ronald D ^c   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

^b Konkuk University   (South Korea)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

16S rRNA; Helicobacter pylori; Hepatic fibrosis; Liver; Senescence marker protein 30

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GENOMIC DNA; IMMUNOGLOBULIN G; REGUCALCIN; RIBOSOME RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CARBON TETRACHLORIDE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; RNA, RIBOSOMAL, 16S;

EID: 70350666632     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.90     Document Type: Article

References (40)

1. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005;21:32-38.
2. Stalke P, Zoltowska A, Orlowski M, et al. Correlation between liver damage and degree of gastric mucosae colonisation by Helicobacter pylori in subjects with parenchymatous liver damage. Med Sci Monit 2001;7(Suppl):271-276.
3. Pellicano R, Leone N, Berrutti M, et al. Helicobacter pylori seroprevalance in hepatitis C virus positive patients with cirrhosis. J Hepatol 2000;33:648-650. (Pubitemid 30736078)
4. Fox JG, Drolet R, Higgins R, et al. Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 1996;34:2479-2482.
5. Ponzetto A, Pellicano R, Redaelli A, et al. Helicobacter pylori infection in patients with hepatitis C virus positive chronic liver diseases. New Microbiol 2003;26:321-328.
6. Ponzetto A, Pellicano R, Leone N, et al. Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med 2000;56:206-210. (Pubitemid 30255942)
7. Calvet X, Navarro M, Gil M, et al. Seroprevalence and epidemiology of Helicobacter pylori infections in patients with cirrhosis. J Hepatol 1997;26:1249-1254.
8. Nilsson H-O, Taneera J, Castedal M, et al. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. Clin Microbiol 2000;38:1072-1076.
9. Avenaud P, Marais A, Monteiro L, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000;89:1431-1439.
10. Desmet VJ, Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 2004;40:860-867.
11. George J, Tsutsumi M, Takase S. Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats. Int J Biochem Cell Biol 2004;36:307-319.
12. Tian XF, Fan XG, Fu CY, et al. Experimental study on the pathological effect of Helicobacter pylori on liver tissues. Zhonghua Gan Zang Bing Za Zhi 2005;13:780-783.
13. Wang X, Willen R, Svensson M, et al. Two-year follow-up of Helicobacter pylori infection in C57BL/6 and Balb/cA mice. APMIS 2003;111:514-522.
14. Taylor NS, Fox JG, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol 1995;42:48-52.
15. Chen R, Fan XG, Huang Y, et al. In vitro cytotoxicity of Helicobacter pylori on hepatocarcinoma HepG2 cells. Ai Zheng 2004;23:44-49.
16. Lee A, O'Rourke J, De Ungria MC, et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-1397.
17. Fu Y, Zheng S, Lin J, et al. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 2008;73:399-409.
18. Oriya K, Yoshikawa M, Ouji Y, et al. Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. Int J Exp Pathol 2008;89:401-409.
19. Zubakhin AA, Kutina SN, Maianski DN. Functional state of the hematopoietic system in different stages of CCL4-induced liver fibrosis in mice. Biull Eksp Biol Med 1992;114:22-24.
20. Mendler MH, Yashar B, Govindarajan S, et al. A novel semi-quantitative histological scoring system for nonalcoholic fatty liver disease: evaluation and clinical correlations. Hepatology 2002;36:407A.
21. Jeong DH, Lee GP, Jeong WI, et al. Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis. World J Gastroenterol 2005;11:1141-1148.
22. Goo MJ, Ki MR, Lee HR, et al. Primary biliary cirrhosis, similar to that in human beings, in a male C57BL/6 mouse infected with Helicobacter pylori. Eur J Gastroenterol Hepatol 2008;20:1045-1048.
23. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J 2005;19:136-138.
24. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005;42:5-13.
25. Jeong WI, DO SH, Kim TH, et al. Acute effects of fast neutron irradiation on mouse liver. J Radiat Res (Tokyo) 2007;48:233-240.
26. Abdel-Hady H, Zaki A, Badra G, et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007;37:1026-1033.
27. Engin A, Zemheri M, Bukan N, et al. Effect of nitric oxide on the hypoglycaemic phase of endotoxaemia. ANZ J Surg 2006;76:512-517.
28. Berry LJ, Smythe DS, Young LG. Effects of bacterial endotoxin on metabolism. I. Carbohydrate depletion and the protective role of cortisone. J Exp Med 1959;110:389-405.
29. Tahashi Y, Matsuzaki K, Date M, et al. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002;35:49-61.
30. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178-191.
31. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem J 1971;123:805-814.
32. Svegliati Baroni G, D'Ambrosio L, Ferretti G, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998;27:720-726.
33. Casini A, Cunningham M, Rojkind M, et al. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991;13:758-765.
34. Sar P, Rath B, Subudhi U, et al. Alterations in expression of senescence marker protein-30 gene by 3,30,5-triiodo-L:-thyronine (T(3)). Mol Cell Biochem 2007;303:239-242.
35. Ishigami A, Fujita T, Handa S, et al. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha-and Fas-mediated apoptosis. Am J Pathol 2002;161:1273-1281.
36. Wadström T, Ljungh A, Willén R. Primary biliary cirrhosis and primary sclerosing cholangitis are of infectious origin!. Gut 2001;49:454.
37. Francavilla A, Ierardi E, Francavilla R, et al. Immunohistochemical detection of Helicobacter pylori vacuolating cytotoxin in the hepatocytes of patients with isolated hypertransaminasaemia. Ital J Gastroenterol Hepatol 1999;3:675-676.
38. Figura N. Hypothesis: Helicobacter toxins and liver. Helicobacter 1996;1:187-189.
39. Day AS, Jones NL, Policova Z, et al. Characterization of virulence factors of mouse-adapted Helicobacter pylori strain SS1 and effects on gastric hydrophobicity. Dig Dis Sci 2001;46:1943-1951.
40. Jung KJ, Ishigami A, Maruyama N, et al. Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol 2004;39:1169-1177.